Zhang Bang-Hua, Chen Hui, Yang Rui, Jiang Zhengyu, Huang Shiyu, Chen Zhiyuan, Liu Cheng, Wang Lei, Liu Xiu-Heng
Department of Urology, Renmin Hospital of Wuhan University, China.
Wuhan University Institute of Urological Disease, China.
FEBS J. 2025 Apr;292(8):2119-2144. doi: 10.1111/febs.17414. Epub 2025 Jan 28.
In our research, we constructed models of renal ischemia-reperfusion (I/R)-exposed acute kidney injury (AKI) and unilateral ureteral obstruction (UUO)-stimulated renal fibrosis (RF) in C57BL/6 mice and HK-2 cells. We firstly authenticated that oral pinocembrin (PIN) administration obviously mitigated tissue damage and renal dysfunction induced by I/R injury, and PIN attenuated UUO-caused RF, as confirmed by the reduced expression of fibrotic markers as well as hematoxylin-eosin (H&E), Sirius red, immunohistochemistry, and Masson staining. Meanwhile, the beneficial role of PIN was again demonstrated in HK-2 cells with hypoxia-reoxygenation (H/R) or transforming growth factor beta-1 (TGF-β1) treatment. Importantly, the "ingredient-target-pathway-disease" network was established through bioinformatics analysis and molecular docking, which showed that PIN may target cytochrome P450 1B1 (CYP1B1) and modulate the mitogen-activated protein kinase (MAPK) pathway to exert its impact during injury. Furthermore, experiments confirmed that PIN usage remarkably constrained CYP1B1 expression, reactive oxygen species (ROS) production, MAPK-pathway-associated inflammation, or apoptosis during I/R injury or UUO exposure. PIN also ameliorated the elevated protein phosphorylation of MAPK pathway components [p38, extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase 1 (JNK ERK and JNK)], which validated the PIN-induced inhibition of the MAPK signaling pathway in renal I/R or UUO injury. Moreover, the AAV9 (adeno-associated virus 9)-packed CYP1B1 or pcDNA-CYP1B1 overexpression plasmid was utilized to treat C57BL/6 mice or HK-2 cells to overexpress CYP1B1, respectively. Notably, CYP1B1 overexpression considerably abolished PIN's restriction impact on ROS generation and MAPK pathway activation. In conclusion, via bioinformatics analysis, molecular docking, animal model, and cellular experiments, we proved that PIN alleviates renal I/R injury/UUO-generated renal fibrosis through regulating the CYP1B1/ROS/MAPK axis.
在我们的研究中,我们构建了C57BL/6小鼠和HK-2细胞中肾缺血再灌注(I/R)诱导的急性肾损伤(AKI)模型以及单侧输尿管梗阻(UUO)刺激的肾纤维化(RF)模型。我们首先证实,口服白杨素(PIN)可明显减轻I/R损伤诱导的组织损伤和肾功能障碍,且PIN可减轻UUO引起的RF,这通过纤维化标志物表达降低以及苏木精-伊红(H&E)染色、天狼星红染色、免疫组织化学和Masson染色得以证实。同时,在经缺氧复氧(H/R)或转化生长因子β1(TGF-β1)处理的HK-2细胞中,再次证明了PIN的有益作用。重要的是,通过生物信息学分析和分子对接建立了“成分-靶点-途径-疾病”网络,结果显示PIN可能靶向细胞色素P450 1B1(CYP1B1)并调节丝裂原活化蛋白激酶(MAPK)途径,从而在损伤过程中发挥作用。此外,实验证实,在I/R损伤或UUO暴露期间,使用PIN可显著抑制CYP1B1表达、活性氧(ROS)生成、MAPK途径相关炎症或细胞凋亡。PIN还改善了MAPK途径成分[p38、细胞外信号调节激酶(ERK)和c-Jun氨基末端激酶1(JNK)]蛋白磷酸化水平的升高,这证实了PIN对肾I/R或UUO损伤中MAPK信号通路的抑制作用。此外,利用腺相关病毒9(AAV9)包装的CYP1B1或pcDNA-CYP1B1过表达质粒分别处理C57BL/6小鼠或HK-2细胞以过表达CYP1B1。值得注意的是,CYP1B1过表达显著消除了PIN对ROS生成和MAPK途径激活的抑制作用。总之,通过生物信息学分析、分子对接、动物模型和细胞实验,我们证明PIN通过调节CYP1B1/ROS/MAPK轴减轻肾I/R损伤/UUO诱导的肾纤维化。